• Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Skip to content
Cannabiz

Cannabiz

The Business of Cannabis

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Home » Roby Zomer

Tag: Roby Zomer

Argent Biopharma and Auscann sign deal to ‘enhance drug development’

by Steve Jones April 23, 2025April 23, 2025

Argent Biopharma and Auscann have joined forces in a deal designed to “accelerate cannabinoid-based pharmaceutical development”. […]

Roby Zomer

New name for MGC Pharma

by Martin Lane April 2, 2024July 16, 2024

Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth

by Steve Jones March 7, 2024March 7, 2024

Company news: MediCann Health; MGC Pharma; Bod Science

by Martin Lane November 8, 2023April 30, 2024
Roby Zomer

MGC Pharma flags restructure in face of ‘dire alternatives’

by Martin Lane September 26, 2023September 28, 2023

Company news: Little Green Pharma; MGC Pharma; Medlab Clinical; Creso Pharma

by Martin Lane February 9, 2023April 29, 2024

Company news: Althea; Cann Group; Emyria; Neurotech; Bod Science; Elixinol; Creso Pharma; MGC Pharma

by Steve Jones and Martin Lane January 31, 2023February 2, 2023

My Account

Sign in

Category

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards

About

  • About/contact us
  • Join
  • Sign in
  • Privacy Policy
  • Website Terms & Conditions
  • Membership Terms & Conditions
  • Submit a Guest Post
  • About cannabis
  • Editorial policy
Cannabiz
  • Linkedin
  • Instagram
© 2025 Cannabiz.